Technology firm Lucideon's CSO appointed to new honorary professor role
Anike Te, chief strategy officer for international materials company Lucideon, will join the University of Bristol as an Aegis Professor in Engineering Biology from September 2022.
The appointment strongly aligns with the University of Bristol’s identity as a world-leading institution for research and innovation with global impact.
In her global role, Anike has experience in identification and adoption of new technologies into industry in healthcare, energy, construction, aerospace and ceramics.
She has recently focused on the potential of synthetic biology to unlock sustainable, next generation materials.
The University of Bristol is widely recognised as a centre of excellence in the UK for synthetic biology research and its commercialisation.
The University hosts the Bristol BioDesign Institute (BBI) which encompasses a research and innovation portfolio of over £100 million.
This includes the new UKRI-funded Bristol Centre for Engineering Biology, BrisEngBio, which is established to accelerate the translation of discovery synthetic biology research to address global challenges and boost the UK’s bioeconomy.
Anike will work across Bristol’s portfolio of synthetic biology projects, surfacing and supporting the translation of novel therapeutics, diagnostics and materials.
She will advise on the growth of our industrial networks to include new industries and new geographical regions, and mentor our new entrepreneurs.
The Aegis Professorship scheme was set up by the Science Partnership Office at the University of Bristol.
In the scheme, visiting professors, who are leaders in their professional field, bring their up-to-date experience of work into academia.
Through guidance and mentorship they facilitate joint working between researchers and external organisations such as industry and government. Anike is the first Aegis professor to be appointed to a cross-Faculty role.
Professor Jens Marklov, Dean of the Faculty of Science of the University of Bristol, said: “We are delighted to welcome Anike Te to the University of Bristol and to our Aegis professorship scheme. Anike’s unique combination of experience allows her to push innovative and novel technical developments into different business sectors.
"Anike has expertise in healthcare, clinical trial development, and the adoption of new technologies within a business context.
"Anike will work with the Bristol Biodesign Institute as well as chemists and biochemists from the Max Planck Bristol Centre for Minimal Biology. We look forward to working with Anike to grow our research capabilities and external networks.”
Professor Jeremy Tavaré, Dean of the Faculty of Life Sciences of the University of Bristol, added: "Bristol has developed a track record of success in translating fundamental synthetic biology into real-world applications.
"This is founded on the appetite of Bristol academics to have a wider impact beyond their academic fields and the vibrant environment for deep tech in and around Bristol.
“Working with international advisors such as Anike will help us to expand the reach and scale of our commercial aspirations, and ultimately to achieve impact of a truly global scale.”
Commenting on her appointment, Anike said: “It is a great honour to join the University of Bristol as an Aegis Professor in Engineering Biology. It’s a great opportunity to bring together academia and industry in an innovative, collaborative approach.
“Lucideon is becoming increasingly involved in synthetic and engineering biology. It’s a very exciting area of science, which touches on many industries and technologies, and creates solutions to real-world issues, both in the UK and internationally.”
